Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Indomethacin Injection Market: By Medical Use, By Distribution Channel, and Geography
Indomethacin Injection Market: By Medical Use, By Distribution Channel, and Geography
Indomethacin Injection Market size was valued at US$ 213.4 million in 2023 and is poised to grow at a significant CAGR of 7.6% over 2024-2030. For a long time, NSAIDs have been an essential treatment for the symptoms of osteoarthritis. NSAIDs exert anti-inflammatory and analgesic effects by allowing the prostaglandin-producing enzyme cyclooxygenase to enter the body (COX). Backache and different joint aches are routinely treated with non-steroidal anti-inflammatory medications (NSAIDs). Injections of indomethacin are NSAIDs. Indomethacin is also used to treat a congenital heart condition known as patent ductus arteriosus in neonates (PDA). Furthermore, the elderly are more likely to experience joint pain. Injections such as platelet-rich plasma and indomethacin are useful in reducing pain and inflammation. Furthermore, in the elderly population, these illnesses will significantly minimize the chance of infection in the affected joint. As a result of these reasons, the market is expected to rise in the future years.
Study Period
2024-2030Base Year
2023CAGR
7.6%Largest Market
EuropeFastest Growing Market
North-America
Swelling and pain and joint stiffness caused by arthritis, gout, bursitis, and tendonitis are treated with indomethacin. It is also used to treat several other ailments. A nonsteroidal anti-inflammatory drug is what this medication is called (NSAID). It works by preventing the formation of certain natural compounds that induce inflammation in your body. This impact aids in the reduction of edema and pain. These factors are driving the indomethacin market. On the other hand, side effects of this injection are reduced urine output, lowered blood sugar, and weight gain, which restrained the market.
The indomethacin injection market in North America is likely to hold the highest revenue share in 2022, and in the following years, it is predicted to increase rapidly. Restructuring the biopharmaceutical and pharmaceutical industries is driving the country's market expansion. Canada has seen substantial improvements in small-medium-sized biopharmaceutical, and pharmaceutical enterprises, as well as contract research organizations, as the tenth-largest market for pharmaceutical sales (CROs).
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 213.4 million |
|
Market CAGR |
7.6% |
|
By Medical Use |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The indomethacin injection market is projected to expand at a CAGR of 6.7% during the forecast period
Hospira, Inc., Fresenius Kabi Aktiengesellschaft, Recordati S.P.A, APP Pharmaceuticals, Bedford Laboratories
North-America is the fastest-growing region for indomethacin injection market
Table of Content
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.